Results 161 to 170 of about 21,338 (215)

Engineered oncolytic virus coated with anti-PD-1 and alendronate for ameliorating intratumoral T cell hypofunction. [PDF]

Exp Hematol Oncol
Zhu Y, Zhang X, Jin J, Wang X, Liu Y, Gao J, Hang D, Fang L, Zhang H, Liu H.   +9 more
europepmc   +1 more source

circ-1584 selectively promotes the antitumor activity of the oncolytic virus M1 on pancreatic cancer. [PDF]

Mol Ther Oncol
Hao T, Li Y, Ren Q, Zeng Y, Gao L, Zhu W, Liang J, Lin Y, Hu J, Yan G, Sun S, Cai J.   +11 more
europepmc   +1 more source

7.Immunotherapy of Glioma using Oncolytic Viruses(PS-2 Pathology and Treatment of Malignant Brain Tumors,The 26^<th> Annual Meeting of The Japanese Congress of Neurological Surgeons)

, 2006
Tomoki Todo
openalex   +2 more sources

Durable antitumor response via an oncolytic virus encoding decoy-resistant IL-18. [PDF]

J Immunother Cancer
Cheng Y, Zhao Y, Liu Y, Zhang Y, Xu D, Sun W, Zhang M, Miao Y, He S, Hou Y, Stupack D, Li E.   +11 more
europepmc   +1 more source

Mathematical modeling of tumor therapy with oncolytic viruses: Effects of parametric heterogeneity on cell dynamics

, 2006
Georgy P. Karev, Artem S. Novozhilov, Eugene V. Koonin   +2 more
openalex   +2 more sources

Neoadjuvant oncolytic virus orienx010 and toripalimab in resectable acral melanoma: a phase Ib trial. [PDF]

Signal Transduct Target Ther
Liu J, Wang X, Li Z, Gao S, Mao L, Dai J, Li C, Cui C, Chi Z, Sheng X, Lai Y, Tan Z, Lian B, Tang B, Yan X, Li S, Zhou L, Wei X, Li J, Guo J, Si L.   +20 more
europepmc   +1 more source

Oncolytic virus and tumor-associated macrophage interactions in cancer immunotherapy. [PDF]

Clin Exp Med
Lecoultre M, Walker PR, El Helali A.
europepmc   +1 more source

Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial. [PDF]

J Immunother Cancer
Tan Z, Wu Y, Fan Z, Gao T, Ding S, Han L, Luo S, Fan Q, Shi J, Bai C, Xue R, Li S, Zhang L, Wang X, Jia L, Zhou L, Liu B, Huang J, Liu J.   +18 more
europepmc   +1 more source

Comparison of differences in immune cells and immune microenvironment among different kinds of oncolytic virus treatments. [PDF]

Front Immunol
Wu X, Fang S.
europepmc   +1 more source